Currently predicting for Wed, 1 May 2024

Trading levels for ACAD

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.46 4.51 %
R2 17.21 2.98 %
R1 17.05 2.03 %
Current price: 16.71
Support S1 16.54 -1.03 %
S2 16.38 -1.98 %
S3 16.12 -3.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 19.98 19.57 %
R2 18.48 10.59 %
R1 16.82 0.658 %
Current price 16.71
Support S1 16.59 -0.718%
S2 16.31 -2.39%
S3 0 .

ACAD Predictions History

7 years ago
JS predicted that ACAD for 2016-09-22 is going $35.33 (-0.81%)

7 years ago
JS predicted that ACAD for 2016-09-09 is going $33.49 (1.21%)

7 years ago
JS predicted that ACAD for 2016-09-08 is going $32.43 (1.34%)

7 years ago
Nick predicted that ACAD for 2016-09-07 is going $32.50 (3.40%)

Rank:

7 years ago
Nick predicted that ACAD for 2016-08-29 is going $33.50 (1.95%)

Rank:

7 years ago
Nick predicted that ACAD for 2016-08-19 is going $33.50 (0.69%)

Rank:

7 years ago
Rick.schondel.207 predicted that ACAD for 2016-05-24 is going $35.45 (3.50%)

Rank:

7 years ago
Gilles.Laberge.199 predicted that ACAD for 2016-05-23 is going $15.62 (-54.11%)

Rank:

7 years ago
Kimberly.Erwin.198 predicted that ACAD for 2016-05-23 is going $34.05 (0.03%)

Rank:
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT